Silexion Therapeutics Ltd. (SLXN)
SLXN Stock Price Chart
Explore Silexion Therapeutics Ltd. interactive price chart. Choose custom timeframes to analyze SLXN price movements and trends.
SLXN Company Profile
Discover essential business fundamentals and corporate details for Silexion Therapeutics Ltd. (SLXN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Aug 2024
Employees
11.00
Website
https://silexion.comCEO
Ilan Hadar
Description
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
SLXN Financial Timeline
Browse a chronological timeline of Silexion Therapeutics Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 12 Aug 2025
EPS came in at -$4.32 falling short of the estimated -$3.15 by -37.14%.
Stock split effective on 29 Jul 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2025
EPS came in at -$3.90 falling short of the estimated -$0.22 by -1.67K%.
Earnings released on 18 Mar 2025
EPS came in at -$20.76 falling short of the estimated -$0.98 by -2.02K%.
Stock split effective on 29 Nov 2024
Shares were split 1 : 9 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$18.27 falling short of the estimated -$7.38 by -147.56%.
Earnings released on 13 Aug 2024
EPS came in at -$0.99 .
Earnings released on 15 May 2024
SLXN Stock Performance
Access detailed SLXN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.